康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03759 康龙化成

未开盘 11-18 16:08:08

14.160

+0.220

+1.58%

最高14.280	最低13.740	成交量439.16万
今开13.840	昨收13.940	日振幅3.87%
总市值253.10亿	流通市值42.76亿	总股本17.87亿
成交额6,139万	换手率1.45%	流通股本3.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":14.16,"timestamp":1731917288017,"preClose":13.94,"halted":0,"volume":4391593,"delay":0,"floatShares":302000000,"shares":1787394297,"eps":0.97293496,"marketStatus":"未开盘","marketStatusCode":0,"change":0.22,"latestTime":"11-18 16:08:08","open":13.84,"high":14.28,"low":13.74,"amount":61391164,"amplitude":0.038737,"askPrice":14.18,"askSize":37500,"bidPrice":14.16,"bidSize":2100,"shortable":3,"etf":0,"ttmEps":1.1434145467876766,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1574870400000,"adjPreClose":13.94,"dividendRate":0.015204,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.44921896577534387,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":27.48,"timestamp":1731913404000,"preClose":28.41,"halted":0,"volume":32676893,"delay":0,"premium":"-52.16"}},"requestUrl":"/m/hq/s/03759","defaultTab":"news","newsList":[{"id":"2483584125","title":"康龙化成获得发明专利授权：“一种On-DNAβ-羟基砜结构化合物、合成方法及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584125","media":"证券之星","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584125?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:36","pubTimestamp":1731699383,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示康龙化成新获得一项发明专利授权，专利名为“一种On-DNAβ-羟基砜结构化合物、合成方法及其应用”，专利申请号为CN202410268143.4，授权日为2024年11月12日。今年以来康龙化成新获得专利授权14个，较去年同期增加了7.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600007935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","BK1141","03759","BK1576","BK0216"],"gpt_icon":0},{"id":"2483427168","title":"康龙化成11月14日主力资金流入7万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483427168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483427168?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:16","pubTimestamp":1731572172,"startTime":"0","endTime":"0","summary":"11月14日, 康龙化成股价跌4.78%，报收14.34元，成交金额1.12亿元，换手率2.54%，振幅5.84%，量比0.66。康龙化成今日主力资金净流入7万元，连续3日净流入，上一交易日主力净流入184万元，今日环比减少96.20%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为26.67%，平均涨幅为1.00%。该股近5个交易日下跌13.93%，主力资金累计净流入845万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入4970万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114161657a236c45c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114161657a236c45c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1576","BK1141"],"gpt_icon":0},{"id":"2483810344","title":"康龙化成(03759)下跌5.05%，报14.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483810344","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483810344?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:54","pubTimestamp":1731567252,"startTime":"0","endTime":"0","summary":"11月14日，康龙化成(03759)盘中下跌5.05%，截至14:54，报14.3元/股，成交8305.82万元。康龙化成是一家国际领先的生命科学研发服务企业，主要为小分子、大分子和细胞与基因治疗药物的研发提供全流程的研发生产服务。公司在中国、美国、英国开展运营，拥有14,000多名员工，服务的主要市场包括北美、欧洲、日本和中国。截至2024年三季报，康龙化成营业总收入88.17亿元、净利润14.22亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14145445284254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300759","BK0216","BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2483284848","title":"康龙化成盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483284848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483284848?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:54","pubTimestamp":1731567247,"startTime":"0","endTime":"0","summary":"2024年11月14日下午盘14时54分，康龙化成股票出现波动，股价大幅下挫5.05%。截至发稿，该股报14.300港元/股，成交量565.091万股，换手率1.87%，振幅5.44%。资金方面，该股资金流入2483.45万港元，流出4148.71万港元。康龙化成股票所在的药品行业中，整体跌幅为0.08%。其相关个股中，先声药业、雅各臣科研制药、金嗓子涨幅较大，振幅较大的相关个股有先声药业、励晶太平洋、艾美疫苗，振幅分别为14.47%、11.70%、10.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114145407abbff123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114145407abbff123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03759","BK1141"],"gpt_icon":0},{"id":"2483289886","title":"南向资金11月13日净卖出康龙化成126.80万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2483289886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483289886?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:30","pubTimestamp":1731547816,"startTime":"0","endTime":"0","summary":"11月13日，南向资金减持康龙化成126.80万股连续3日减持。截止当日收盘，港股通共持有康龙化成18794.98万股，占流通股62.32%。康龙化成近5个交易日下跌7.15%，港股通累计减持140.44万股；近20个交易日上涨9.29%，港股通累计增持777.78万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114093210abbf18a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114093210abbf18a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03759","BK1141"],"gpt_icon":0},{"id":"2483015169","title":"康龙化成盘中异动 急速跳水5.11%报14.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483015169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483015169?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:27","pubTimestamp":1731464850,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘10时27分，康龙化成股票出现异动，股价急速下挫5.11%。截至发稿，该股报14.860港元/股，成交量392.55万股，换手率1.30%，振幅6.13%。资金方面，该股资金流入1843.11万港元，流出2899.33万港元。康龙化成股票所在的药品行业中，整体跌幅为0.31%。其相关个股中，泰凌医药、开拓药业-B、中生联合涨幅较大，振幅较大的相关个股有开拓药业-B、康龙化成、艾美疫苗，振幅分别为14.84%、6.13%、5.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113102730a2321963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113102730a2321963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03759","BK1141"],"gpt_icon":0},{"id":"2482719971","title":"多重利好提振医药港股 机构称短期仍面临这一风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2482719971","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482719971?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:05","pubTimestamp":1731380709,"startTime":"0","endTime":"0","summary":"　　财联社11月12日讯 受近日多重利好推动，今日港股医药股多数走强。截至发稿，凯莱英、药明康德、康龙化成、昭衍新药分别上涨3.65%、3.36%、3.11%、2.72%。　　消息方面，药明康德近日宣布，公司在2024年标普全球企业可持续发展评估中获得行业最高分，位列全球“生命科学工具与服务”领域第一。特朗普上台后，可能会导致美联储降息进程放缓，从而影响海外生物医药融资复苏，以及CXO行业短期内海外新签订单速度及订单转化收入周期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/jjxw/2024-11-12/doc-incvupap6475774.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-12/doc-incvupap6475774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["LU0708995583.HKD","LU2125910500.SGD","LU1046422090.SGD","BK1583","BK1141","LU2045819591.USD","06127","BK1191","BK1576","03759","06821","LU0320764599.SGD","LU2242644610.SGD","02359","LU0052750758.USD"],"gpt_icon":0},{"id":"2482371314","title":"医药外包概念股集体走高 凯莱英涨6.14% 机构指降息环境下生物医药融资将反弹 板块需求将复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2482371314","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482371314?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:17","pubTimestamp":1731377825,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股集体走高，截至发稿，凯莱英 涨6.14%，药明康德涨4.16%，康龙化成涨3.86%，药明生物涨3.57%，泰格医药涨3.18%。消息面上，招银国际表示，第三季度，药明康德、康龙化成、凯莱英等以海外CDMO业务为主的企业持续受益于海外研发需求复苏，新订单快速增长。该行认为，生物安全法案在年内单独立法完成的窗口期非常有限。降息环境下全球生物医药融资将反弹，带动CXO需求复苏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112101716abb7b119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112101716abb7b119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","LU0708995583.HKD","LU0320764599.SGD","LU0052750758.USD","LU2125910500.SGD","BK1574","09939","BK1161","LU2045819591.USD","LU2242644610.SGD","02359","LU1046422090.SGD","03759","BK1141","BK1576","BK1583","06821"],"gpt_icon":0},{"id":"2482718525","title":"康龙化成盘中异动 早盘大幅上涨5.10%报16.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482718525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482718525?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:10","pubTimestamp":1731377437,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘10时10分，康龙化成股票出现波动，股价大幅拉升5.10%。截至发稿，该股报16.900港元/股，成交量436.74万股，换手率1.45%，振幅5.22%。资金方面，该股资金流入3734.32万港元，流出2352.3万港元。康龙化成股票所在的药品行业中，整体涨幅为0.44%。其相关个股中，凯莱英、山东新华制药股份、康龙化成涨幅较大，振幅较大的相关个股有君圣泰医药-B、凯莱英、信达生物，振幅分别为11.30%、8.46%、7.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112101037a22e29a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112101037a22e29a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1141","BK1576"],"gpt_icon":0},{"id":"1102087450","title":"异动解读 | 康龙化成签署重点企业协议 助力股价大涨5.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102087450","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102087450?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:05","pubTimestamp":1731377130,"startTime":"0","endTime":"0","summary":"康龙化成今日午间股价大涨5.1%,报收10.2港元。根据新闻报道,康龙化成今日与香港特区政府签署了重点企业协议,成为17家与政府签约的重点企业伙伴之一。这标志着康龙化成在香港的产业发展进入新阶段,未来将获得更多政策支持和便利条件,助力公司业务在港扩张和发展。投资者看好公司未来在香港乃至大湾区的发展前景,因此在消息公布后纷纷入场买盘,推动了今日的大涨行情。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 康龙化成签署重点企业协议 助力股价大涨5.1%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03759"],"gpt_icon":0},{"id":"2482274792","title":"引进办：17家重点企业签约落户或扩展港业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2482274792","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482274792?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:17","pubTimestamp":1731313020,"startTime":"0","endTime":"0","summary":"引进重点企业办公室举办“重点企业伙伴签约仪式”，欢迎新一批重点企业落户香港或扩展其在香港的业务。在财政司司长陈茂波见证下，17家重点企业参与签约，成为特区政府的重点企业伙伴。这些企业大部分都会在香港设立全球或地区总部。他们连同早前引进的约50家重点企业，在未来数年将会在香港合共投资约420亿元，创造超过17,000个职位。在投资香港的同时，也会积极带动其产业链上、中、下游的企业来到香港。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190801150919734_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190801150919734_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395688/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","BK1141","03759"],"gpt_icon":0},{"id":"2482210444","title":"康龙化成11月8日获南向资金加仓256.76万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482210444","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482210444?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:30","pubTimestamp":1731288619,"startTime":"0","endTime":"0","summary":"11月8日, 南向资金增持康龙化成256.76万股。截止当日收盘，港股通共持有康龙化成19071.32万股，占流通股63.23%。康龙化成近5个交易日上涨5.52%，港股通累计增持346.37万股；近20个交易日下跌0.12%，港股通累计增持1325.04万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111093318abb43e11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111093318abb43e11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2481252126","title":"中原证券：给予康龙化成增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481252126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481252126?lang=zh_cn&edition=full","pubTime":"2024-11-08 18:01","pubTimestamp":1731060083,"startTime":"0","endTime":"0","summary":"中原证券股份有限公司李琳琳近期对康龙化成进行研究并发布了研究报告《季报点评：3Q业绩环比改善，CMC新签订单增速较快》，本报告对康龙化成给出增持评级，当前股价为30.55元。　　预计公司2024-2026年每股收益分别为0.98元，1.10元和1.30元，对应11月7日收盘价，市盈率分别为31.58倍，28.17倍和23.77倍，给予公司“增持”的投资评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800031425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601375","300759","03759"],"gpt_icon":0},{"id":"2481112504","title":"港股异动 | CRO概念股普遍承压 美国大选结果影响情绪 机构指生物安全法单独立法概率或提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2481112504","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481112504?lang=zh_cn&edition=full","pubTime":"2024-11-08 14:32","pubTimestamp":1731047530,"startTime":"0","endTime":"0","summary":"消息面上，美国大选结果落地，特朗普当选新一届美国总统。浦银国际认为，此次大选结果主要在短期影响中国CXO行业及中国创新药企市场情绪，美国长期限制中国医药企业的政策大方向基本维持不变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","01548","HK0000306701.USD","01873","HK0000320264.USD","BK1583","LU2045819591.USD","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","LU0320764599.SGD","02359","HK0000306685.HKD","LU0052750758.USD","LU2242644610.SGD","HK0000320223.HKD","BK1576","03759"],"gpt_icon":0},{"id":"2481994312","title":"康龙化成11月6日获南向资金加仓220.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481994312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481994312?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:30","pubTimestamp":1730943018,"startTime":"0","endTime":"0","summary":"11月6日, 南向资金增持康龙化成220.85万股。截止当日收盘，港股通共持有康龙化成18935.42万股，占流通股62.79%。康龙化成近5个交易日上涨6.43%，港股通累计增持629.09万股；近20个交易日下跌10.49%，港股通累计增持2121.10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107093239a21e6016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107093239a21e6016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1141","BK1576"],"gpt_icon":0},{"id":"2481616826","title":"龙头股单季度业绩降幅收窄，CRO板块能否迎来拐点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2481616826","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481616826?lang=zh_cn&edition=full","pubTime":"2024-11-06 11:50","pubTimestamp":1730865004,"startTime":"0","endTime":"0","summary":"至6日午间收盘时，药明康德、康龙化成、凯莱英、昭衍新药等行业龙头股连续三个交易日上涨。从近期披露的2024年三季度报告来看，相关企业第三季度业绩降幅收窄。药明康德2024年第三季度营收同比下降1.96%，第二季度营收降幅为6.55%；第三季度净利润降幅为17.02%，第二季度净利润降幅为26.94%。从在手订单和执行情况来看，第四季度新兴业务将重新恢复增长态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106115005a21a93e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106115005a21a93e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","BK1583","LU0052750758.USD","BK1191","02359","LU2125910500.SGD","603259","BK1576","LU2045819591.USD","03759","06821","LU0708995583.HKD","LU1046422090.SGD","LU0320764599.SGD","BK1141"],"gpt_icon":0},{"id":"2481108546","title":"港股异动 | CRO概念普遍走高 医保谈判支持创新药  降息环境下全球生物医药融资将反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2481108546","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481108546?lang=zh_cn&edition=full","pubTime":"2024-11-05 14:34","pubTimestamp":1730788467,"startTime":"0","endTime":"0","summary":"招银国际表示，第三季度，药明康德、康龙化成、凯莱英等以海外CDMO业务为主的企业持续受益于海外研发需求复苏，新订单快速增长。该行认为，生物安全法案在年内单独立法完成的窗口期非常有限。虽然生物安全法案在美国众议院获得通过，但是民主党议员有49%未投赞成票，其中包括36%的反对票。预计《生物安全法案》在民主党主导的参议院将面临更大的阻力。降息环境下全球生物医药融资将反弹，带动CXO需求复苏。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0572944931.SGD","LU0516423091.SGD","06978","LU0043850808.USD","LU0140636845.USD","LU2045819591.USD","LU0979878070.USD","LU1880383366.USD","LU0348825331.USD","BK1574","LU1794554557.SGD","LU0181495838.USD","LU1242518857.USD","LU0856984785.SGD","LU0516422440.USD","LU0516422952.EUR","LU0326950275.SGD","LU0823426480.USD","159992","BK1583","LU0051755006.USD","02269","LU1242518931.SGD","BK1576","LU0359202008.SGD","SG9999002562.SGD","BK1191","LU0052750758.USD","BK1141","LU0039217434.USD","LU0307460666.USD","LU2242644610.SGD","06821","LU0708995583.HKD","LU0359201612.USD","LU0588546209.SGD","399441","LU0417516738.SGD","LU0327786744.USD","03759","02359","LU0456827905.SGD","BK1521","SG9999002463.SGD","BK1610","LU0456846285.SGD","03347","LU1720050803.USD","161726"],"gpt_icon":1},{"id":"2480275923","title":"《股市简讯》中国康龙化成A/H股齐涨，花旗上调目标价料全球CDMO需求改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2480275923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480275923?lang=zh_cn&edition=full","pubTime":"2024-11-04 15:26","pubTimestamp":1730705198,"startTime":"0","endTime":"0","summary":"《股市简讯》中国康龙化成A/H股齐涨，花旗上调目标价料全球CDMO需求改善* 为制药公司代工研发药物的中国康龙化成A股300759.SZ周一盘中一度升5.2%，报30.28元，终场收涨2.8%；其H股3759.HK亦最多上扬5%，报15.98港元。* 花旗在报告中表示，将康龙化成A股的目标价由25元上调至30元，H股的目标价由28港元上调至33港元。H股评级为“买入”，但由于估值原因，将A股评级降为“中性”。* 康龙化成H股今年迄今跌2.1%，同期恒生指数.HSI大幅上扬20.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nL4S3MB0DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","300759"],"gpt_icon":0},{"id":"2480104103","title":"南向资金11月1日净买入康龙化成143.65万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2480104103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480104103?lang=zh_cn&edition=full","pubTime":"2024-11-04 09:30","pubTimestamp":1730683818,"startTime":"0","endTime":"0","summary":"11月1日, 南向资金增持康龙化成143.65万股，连续3日增持。截止当日收盘，港股通共持有康龙化成18724.96万股，占流通股62.09%。康龙化成近5个交易日下跌4.52%，港股通累计增持532.75万股；近20个交易日下跌4.28%，港股通累计增持1972.44万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093231ab9c37bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093231ab9c37bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03759"],"gpt_icon":0},{"id":"2480887122","title":"开源证券：给予康龙化成买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887122?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:35","pubTimestamp":1730471741,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对康龙化成进行研究并发布了研究报告《公司信息更新报告：新签订单稳健增长，连续三个季度实现温和复苏》，本报告对康龙化成给出买入评级，当前股价为28.79元。最新盈利预测明细如下：该股最近90天内共有15家机构给出评级，买入评级11家，增持评级3家，中性评级1家；过去90天内机构目标均价为24.18。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100049334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","161027","03759"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharmaron.com","stockEarnings":[{"period":"1week","weight":-0.1194},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.6054},{"period":"6month","weight":0.3162},{"period":"1year","weight":-0.3158},{"period":"ytd","weight":-0.0831}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康龙化成（北京）新药技术股份有限公司是一家在发现、开发及制造小分子药物、细胞疗法及基因疗法的过程中提供研究及制造服务组合，以及提供医疗工具及临床研究测试服务的中国公司。该公司运营四个业务分部。实验室服务分部包括实验室化学、药物代谢及药代动力学╱吸收、分布、代谢及排泄、生物学、安全评估及发现生物制剂服务。CMC服务分部从事工艺开发和预制剂生产和分析业务。临床研究服务分部包括临床研究、现场管理组织、监管生物分析及放射性标记科学服务。大分子和细胞与基因治疗服务分部从事大分子药物的发现和开发生产、细胞基因治疗方法开发等业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.039133},{"month":2,"riseRate":0.4,"avgChangeRate":-0.057335},{"month":3,"riseRate":0.4,"avgChangeRate":-0.053592},{"month":4,"riseRate":1,"avgChangeRate":0.081042},{"month":5,"riseRate":0.6,"avgChangeRate":-0.002281},{"month":6,"riseRate":0.6,"avgChangeRate":0.074074},{"month":7,"riseRate":0.6,"avgChangeRate":0.019414},{"month":8,"riseRate":0.4,"avgChangeRate":-0.022557},{"month":9,"riseRate":0.6,"avgChangeRate":0.088643},{"month":10,"riseRate":0.6,"avgChangeRate":-0.046722},{"month":11,"riseRate":0.4,"avgChangeRate":0.085042},{"month":12,"riseRate":0.6,"avgChangeRate":0.046869}],"exchange":"SEHK","name":"康龙化成","nameEN":"PHARMARON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,03759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}